Filing Details
- Accession Number:
- 0001179110-20-008594
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-30 19:29:55
- Reporting Period:
- 2020-07-29
- Accepted Time:
- 2020-07-30 19:29:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1235010 | Momenta Pharmaceuticals Inc | MNTA | Biological Products, (No Disgnostic Substances) (2836) | 043561634 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1706857 | Santiago Arroyo | C/O Momenta Pharmaceuticals, Inc. 301 Binney Street Cambridge MA 02142 | Svp, Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-07-29 | 10,156 | $12.76 | 19,004 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-07-29 | 22,500 | $17.20 | 41,504 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-07-29 | 39,618 | $30.00 | 1,886 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-07-29 | 10,156 | $0.00 | 10,156 | $12.76 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-07-29 | 22,500 | $0.00 | 22,500 | $17.20 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
83,858 | 2020-02-11 | 2029-02-11 | No | 4 | M | Direct |
59,248 | 2019-09-20 | 2027-06-20 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan.